Immunotherapy is one of the fastest-moving subfields of oncology. New checkpoint combinations, CAR-T variants, TCR engineering, and bispecific antibodies reach trial monthly. Relaylit tracks PubMed, Europe PMC, and arXiv (for bioinformatics/ML methods) in one weekly digest.
Oncology immunotherapy
Checkpoint inhibitors, CAR-T, bispecifics — mechanistic and clinical research.
Example brief
Where Relaylit searches for this topic
Ready to track this?